首页> 外文期刊>Experimental and therapeutic medicine >Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique
【24h】

Study on extracellular matrix metalloproteinase inducer and human epidermal growth factor receptor-2 protein expression in papillary thyroid carcinoma using a quantum dot-based immunofluorescence technique

机译:基于量子点的免疫荧光技术研究甲状腺乳头状癌中细胞外基质金属蛋白酶诱导剂和人表皮生长因子受体2蛋白的表达

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to investigate the association of extracellular matrix metalloproteinase inducer (EMMPRIN) and human epidermal growth factor receptor (HER)-2 protein expression in papillary thyroid carcinoma with lymph node metastasis (LNM), as well as the correlation between the two types of protein expression. A quantum dot-based immunofluorescence technique was used to detect EMMPRIN and HER-2 protein expression in 75 papillary thyroid carcinoma cases (including 70 cases of papillary thyroid carcinoma tissues and 5 cases of peri-tumor tissues). The positive rate and expression of EMMPRIN and HER-2 were compared and observed. The positive rate of EMMPRIN was 75.71% in papillary thyroid carcinoma tissues and 20.00% in peri-tumor tissues (P<0.05). The positive rate of HER-2 was 45.71% in papillary thyroid carcinoma tissues and 0% in peri-tumor tissues (P>0.05). The expression of EMMPRIN and HER-2 in papillary thyroid carcinoma was significantly associated with LNM (P<0.05). In addition, in the 70 papillary thyroid carcinoma tissues, the expression of EMMPRIN and HER-2 was positively and significantly correlated. In conclusion, this study demonstrates that the co-evolution of EMMPRIN and HER-2 may promote the occurrence and development of papillary thyroid carcinoma and LNM.
机译:本研究的目的是研究甲状腺乳头状癌中细胞外基质金属蛋白酶诱导剂(EMMPRIN)和人类表皮生长因子受体(HER)-2蛋白表达与淋巴结转移(LNM)的关系,以及两者之间的相关性。两种类型的蛋白质表达。基于量子点的免疫荧光技术用于检测75例甲状腺乳头状癌(包括70例甲状腺乳头状癌组织和5例癌旁组织)的EMMPRIN和HER-2蛋白表达。比较和观察EMMPRIN和HER-2的阳性率和表达。甲状腺乳头状癌组织中EMMPRIN的阳性率为75.71%,肿瘤周围组织为20.00%(P <0.05)。甲状腺乳头状癌组织中HER-2阳性率为45.71%,肿瘤周围组织为0%(P> 0.05)。甲状腺乳头状癌中EMMPRIN和HER-2的表达与LNM显着相关(P <0.05)。此外,在70例甲状腺乳头状癌组织中,EMMPRIN和HER-2的表达呈正相关且显着相关。总之,这项研究表明,EMMPRIN和HER-2的共同进化可能促进乳头状甲状腺癌和LNM的发生和发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号